FundComb

Investment and M&A transaction comps

CPG Investment & M&A Transaction Comps

Global CPG and consumer brand investments, capital raises and M&A transactions, including food, beverage, beauty, personal care, supplements and adjacent branded consumer categories.

Consumer CPG Beauty Supplements
101
Reviewed transactions
69
With price data
4.5x
Median EV or valuation / revenue
17.0x
Median EV or valuation / EBITDA
Year Transactions Priced Median EV or valuation / revenue Median EV or valuation / EBITDA
2026 6 5 2.9x 9.9x
2024 6 6 4.2x 16.0x
2023 14 12 4.1x 21.6x
2022 16 6 4.9x 20.4x
2021 18 14 4.7x 15.0x
2020 10 5 4.2x 14.7x
2019 6 5 4.4x 18.7x
2018 4 4 4.5x 21.2x

Sortable transaction comps

CPG transaction table

Filter transactions

Narrow the table without crowding the main view.

Clear all filters

Rows with reported value

17 / 25

Acquisition value, USD

USD 55B

Investment capital, USD

-

Median EV or valuation / revenue

4.5x

Columns

Show columns

Select up to 12 rows across filters and pages, then share or export the set.

25 shown of 101 matching transactions. Click any transaction row for more detail.

Select for comparison
2019-05-09 Perrigo 750 2.6x -
CPGOral Care
+3
Oral Self CarePrivate LabelToothbrushes
OLLY Nutrition
Control
 2019-04-18 Unilever Undisclosed 5.0x 20.0x
CPGGummy Vitamins
+2
Vitamins & SupplementsWellness Supplements
2018-10-23 Johnson & Johnson 2,100 4.5x 22.0x
CPGBeauty
+1
Skincare
2018-07-17 P&G 250 4.5x -
CPGPrestige Beauty
+1
Skincare
2018-07-02 ADM 243 5.6x 21.2x
ConsumerCPG
+6
Animal HealthDietary SupplementsMicrobiomeNutraceuticalsProbiotic ProductsProbiotics
Nutranext
Control
 2018-03-12 Clorox 700 3.5x 14.0x
CPGDietary Supplements
+3
VitaminsVitamins & SupplementsVMS
2017-12-26 Mallinckrodt 1,200 4.6x -
Gastrointestinal PharmaceuticalsSpecialty Pharmaceuticals
2017-12-18 Colgate-Palmolive 730 7.3x -
CPGProfessional Skincare
+2
SkincareSunscreen
2017-12-05 Nestlé 2,300 3.3x 19.0x
CPGConsumer Health
+4
Dietary SupplementsNutraceuticalsVitaminsVitamins & Supplements
Ganeden
Control
 2017-10-11 Kerry Group Undisclosed 6.0x 20.0x
ConsumerIngredients
+2
ProbioticsProbiotics Ingredients
2017-07-01 Haitong International Zhonghua Finance Acquisition Fund I, L.P. 190 2.2x 6.3x
CPGMedical Aesthetics
+2
Professional SkincareSkincare
Nutraceutical
Control
 2017-05-22 HGGC Undisclosed 1.8x 9.9x
CPGNutraceuticals
+1
Vitamins & Supplements
2017-02-13 Allergan 2,470 6.2x -
ConsumerBody Contouring Devices
+3
Medical AestheticsMedical Aesthetics / Body Contouring DevicesNon Invasive Fat Reduction
2017-02-10 Reckitt Benckiser 16,600 4.8x 17.6x
CPGBaby Formula
+3
Infant FormulaInfant Formula & NutritionInfant Nutrition
Viviscal
Control
 2017-01-20 Church & Dwight Undisclosed 3.6x 17.8x
CPGHair Care
+2
Hair Growth SupplementsHair Growth Supplements / Personal Care
2017-01-10 L'Oréal 1,300 7.7x -
CPGAcne Care
+2
Dermatology SkincareSkincare
Vitaco
Control
 2016-08-01 Primavera Capital Undisclosed 1.5x 14.7x
CPGHealth Foods
+5
Protein PowdersSports NutritionSupplementsSupplements And Health FoodsVitamins
2016-07-20 Unilever 1,000 6.6x -
CPGGrooming
+4
Grooming / Men'S Personal CareMen'S Personal CareShaving ProductsSubscription Commerce
2016-06-27 Sanofi 7,300 4.4x 16.1x
ConsumerConsumer Healthcare
+2
Consumer Healthcare / OTC PharmaceuticalsOTC Pharmaceuticals
Swisse
Control (3%)
 2015-09-17 Biostime 1,670 - 15.5x
CPGSkincare
+4
SupplementsVitaminsVitamins & SupplementsWellness Products
2015-06-17 Allergan 2,100 - -
Aesthetic InjectablesBiopharmaceuticals
+2
Life Sciences Medical AestheticsMedical Aesthetics
2014-05-06 Bayer 14,200 6.5x 21.0x
ConsumerConsumer Health
+2
Consumer Health / OTC PharmaceuticalsOTC Pharmaceuticals
2012-11-22 Reckitt Benckiser Undisclosed 4.2x 19.1x
ConsumerSupplements
+3
VitaminsVitamins & SupplementsVMS
2010-07-21 Reckitt Benckiser Undisclosed 3.5x 20.5x
ConsumerConsumer Healthcare
+1
Consumer Healthcare Products
- Griesson-de Beukelaer Undisclosed - -
CPGBaked Goods
+3
CookiesFoodWafer Cookies
FundComb transaction comps are informational only. Prices are shown as estimated enterprise value where available, with USD used as the default sorting currency; revenue and EBITDA multiples are shown where available. Values may be estimated, rumored, incomplete or derived from public information and should not be relied upon as financial, investment or valuation advice.